Insulet s Omnipod® 5 Automated Insulin Delivery System Pivotal Studies Demonstrate Improved Outcomes Across the Lifespan from Ages 2 to 70 years apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Company
Insulet Corporation is primarily engaged in the development, manufacture and sale of its proprietary Omnipod System, a continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod Insulin Management System (Omnipod), the Omnipod DASHTM Insulin Management System (Omnipod DASH) and its digital mobile Omnipod platform. The Omnipod System features two devices: a.
Insulet (PODD) Receives a Hold from BTIG markets.co - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from markets.co Daily Mail and Mail on Sunday newspapers.
Posted on 399
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod
® Insulin Management System (Omnipod System), today announced the launch of the Omnipod DASH
® Insulin Management System (Omnipod DASH System) in Canada.
“We’re thrilled to bring this convenient and easy-to-use insulin delivery system to Canada,” said Bret Christensen, Chief Commercial Officer of Insulet. “The Omnipod DASH System’s sleek, touchscreen Personal Diabetes Manager (PDM), combined with the existing benefits of Pod therapy, will provide Canadian users even more freedom, flexibility, and discretion to simplify their diabetes management.”
The Omnipod DASH System combines a tubeless, wearable, waterproof